{"id":"W2580774047","doi":"10.1182/blood.v106.11.923.923","title":"Bendamustine HCl (TREANDATM) Treatment in Combination with Rituximab Results in Objective Responses in Patients with Refractory/Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin’s Lymphoma: Results from Phase II Multicenter Study (SDX-105-02).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Northeast Cancer Centre; Hôpital Notre-Dame; Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Mantle cell lymphoma; Medicine; Rituximab; Internal medicine; Follicular lymphoma; Gastroenterology; Non-Hodgkin's lymphoma; Population; Lymphoma; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008939791,0.0006727386,0.0009760639,0.0002774039,0.0002003989,0.0004607319,0.0004647054,0.0003675848,0.0009371401],"category_scores_gemma":[0.0005716588,0.0002957027,0.0005009741,0.000282522,0.0003157862,0.0003188061,0.000153067,0.0009814332,0.000247937],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005834111,"about_ca_system_score_gemma":0.0005359779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001316592,"about_ca_topic_score_gemma":0.003246826,"domain_scores_codex":[0.9997812,0.00008802344,0.00001721378,0.00004006791,0.00003141987,0.00004205429],"domain_scores_gemma":[0.9997099,0.00006589542,0.00005367661,0.00002228863,0.0000194647,0.0001288516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2947155,0.04234143,0.1207692,0.0008813304,0.003033872,0.001021926,0.0008518056,0.004097461,0.1935386,0.0001209332,0.004148308,0.3344796],"study_design_scores_gemma":[0.1782259,0.4423035,0.3455817,0.00008351803,0.001608332,0.002234071,0.0002081338,0.003556048,0.0212776,0.0000996517,0.00477404,0.00004749882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983943,0.0008146014,0.00008194861,0.00004478827,0.00001036999,0.0001307687,0.0001420496,0.00002426479,0.0003568856],"genre_scores_gemma":[0.9979664,0.0004553708,0.0003310802,0.0001183066,0.00003518784,0.00009831174,0.0007093989,0.000007021713,0.0002788116],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001316592,"threshold_uncertainty_score":0.0047279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008431412163650037,"score_gpt":0.2465479917324722,"score_spread":0.2381165795688222,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}